The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
PLGA-PEG-RA-based polymeric micelles for tumor targeted delivery of irinotecan
Abstract
To develop an effective therapeutic treatment, the potential of poly (lactic-co-glycolic acid)-polyethylene glycol-retinoic acid (PLGA-PEG-RA) polymeric micelles for targeted delivery of irinotecan to hepatocellular carcinoma (HepG2) and colorectal cancer cell lines (HT-29) was evaluated. PLGA-PEG-RA was synthesized by amide reaction of PLGA with NH2–PEG–NH2 and then PLGA-PEG-NH2 with RA and confirmed by FTIR and 1H NMR spectroscopy. Irinotecan-loaded nanomicelles were prepared using thin-film hydration method and the impact of various formulation variables on their particle size (PS), polydispersity index (PDI), zeta potential (ZP), entrapment efficiency (EE), and mean release time (MRT) were assessed using a Taguchi design. TEM was used to observe morphology of the nanomicelles and the CMC was determined by fluorescence spectroscopy. Adopted PLGA-PEG-RA nanomicelle exhibited PS of 160 ± 9.13 nm, PDI of 0.20 ± 0.05, ZP of −24.9 ± 4.03 mV, EE of 83.9 ± 3.61%, MRT of 3.28 ± 0.35 h, and CMC value of 25.7 μg/mL. Cytotoxicity of the targeted nanomicelles on HepG2 and HT-29 cell lines was significantly higher than that of non-targeted nanomicelles and the free drug. These results suggest that PLGA-PEG-RA nanomicelles could be an efficient delivery system of irinotecan for targeted therapy of colorectal cancer and hepatocellular carcinoma.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Polymeric polylactide-co-glycolic acid (PLGA) NPs were also shown to increase the cytotoxicity of chemotherapy drugs, such as 5-FU and irinotecan, in CRC cell lines [113,114].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [113]
Citations
Cites
Modeling and comparison of dissolution profiles
Costa, P., & Sousa Lobo, J. M. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00095-1 · Cited by 5,509
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Ritger, P. L., & Peppas, N. A. (1987) · Journal of Controlled Release · doi:10.1016/0168-3659(87)90034-4 · Cited by 3,830
Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
Huang, M., Ye, Y., Chen, Sr., Chai, Jr., Lu, J., Zhoa, L., Gu, L., & Wang, Z. (1988) · Blood · doi:10.1182/blood.v72.2.567.567 · Cited by 2,445
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Structure and design of polymeric surfactant-based drug delivery systems
Torchilin, V. P. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00299-1 · Cited by 1,822
A simple equation for the description of solute release. III. Coupling of diffusion and relaxation
Peppas, N. A., & Sahlin, J. J. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90306-2 · Cited by 1,771
de Thé, H., Chomienne, C., Lanotte, M., Degos, L., & Dejean, A. (1990) · Nature · doi:10.1038/347558a0 · Cited by 1,355
Formulation of functionalized PLGA-PEG Nanoparticles for in vivo targeted drug delivery
Cheng, J., Teply, B. A., Sherifi, I., Sung, J., Luther, G., Gu, F. X., Levy-Nissenbaum, E., Radovic-Moreno, A. F., Langer, R., & Farokhzad, O. C. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.09.047 · Cited by 1,273
Hsiang, Y. H., Lihou, M. G., & Liu, L. F. (1989) · PubMed · Cited by 1,028
Research works printed but not linked: 6
- Gershenson DM. 2002. Irinotecan in epithelial ovarian cancer. Oncology (Williston Park). 16:29–31.
- Green MR, Harper M, Safa A, Sherman CA, Mushtaq CM, Bahadori H, Brescia FJ, Rocha Lima CM. 2000. Irinotecan in the management of patients with pancreatic cancer. Oncology (Williston Park). 14(12 Suppl 14):31–33.
- 10.1186/2008-2231-22-30 · DOI
- Kaparissides C, Alexandridou S, Kotti K, Chaitidou S. 2006. Recent advances in novel drug delivery systems. J Nano Tech. 2:1–11.
- Mahalwara A, Sharmaa A, Sahub R. 2012. Evaluation of receptor mediated endocytosis on cellular internalization: a comparative study of pegylated nanoparticles and folate anchored pegylated nanoparticles on mda-mb-231 cells. Int J Biol Pharm Res. 3:431–443.
- 10.1002/(sici)1097-0142(19981015)83:8<1471::aid-cncr1>3.0.co;2-6 · DOI
Cited by
A Recent Review on Cancer Nanomedicine
Giri, P. M., Banerjee, A., & Layek, B. (2023) · Cancers · doi:10.3390/cancers15082256 · Cited by 182
Perinelli, D. R., Cespi, M., Bonacucina, G., & Palmieri, G. F. (2019) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-019-00442-2 · Cited by 162
Rajpoot, K., & Jain, S. K. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.02.132 · Cited by 104
Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
Haynes, J., & Manogaran, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051988 · Cited by 82
“Polymeric polylactide-co-glycolic acid (PLGA) NPs were also shown to increase the cytotoxicity of chemotherapy drugs, such as 5-FU and irinotecan, in CRC cell lines [113,114].”
Topoisomerase inhibitors: Pharmacology and emerging nanoscale delivery systems
Dehshahri, A., Ashrafizadeh, M., Afshar, E. G., Pardakhty, A., Mandegary, A., Mohammadinejad, R., & Sethi, G. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104551 · Cited by 65
Metadata
- Authors
- Emami, J., Maghzi, P., Hasanzadeh, F., Sadeghi, H., Mirian, M., & Rostami, M.
- Affiliations
- Isfahan University of Medical Sciences (IR)
- Corresponding author
- Emami, Jaber
- Venue
- Pharmaceutical Development and Technology
- Publisher
- Informa UK Limited
- Published
- 2017-07-07
- Volume
- 23
- Issue
- 1
- Pages
- 41-54
- ISSN
- 1083-7450 (ISSN-L)
- 1097-9867
- OpenAlex
- W2624887519
- Cited by
- 36
- References
- 63
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 5 · 2023: 6 · 2022: 6 · 2021: 3 · 2020: 5 · 2019: 4 · 2018: 1
- FWCI
- 0.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pharmaceutical Development and Technology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Isfahan University of Medical Sciences
- Research Department of Isfahan University of Medical Sciences, Isfahan, I.R. Iran (391408)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- polymeric micelles, irinotecan, targeted drug delivery, hepatocellular carcinoma, colorectal cancer, retinoic acid, PEGylation, cytotoxicity, drug release, Taguchi method
- MeSH terms
- Irinotecan, Polylactic Acid-Polyglycolic Acid Copolymer, Camptothecin, Drug Carriers, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Micelles, Particle Size, Polyethylene Glycols, Polyglactin 910, Polyglycolic Acid, Tretinoin, Drug Delivery Systems, HT29 Cells, Lactic Acid, Cell Line, Tumor, Nanoparticles, Hep G2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PLGA-PEG-RA-based polymeric micelles for tumor targeted delivery of irinotecan. https://app.cochat.ai/papers/10.1080/10837450.2017.1340950
- The paper
- Emami, J., Maghzi, P., Hasanzadeh, F., Sadeghi, H., Mirian, M., & Rostami, M. (2018). PLGA-PEG-RA-based polymeric micelles for tumor targeted delivery of irinotecan. Pharmaceutical Development and Technology. https://doi.org/10.1080/10837450.2017.1340950
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.